Deficiency Or Absence Of Endogenous Testosterone — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for deficiency or absence of endogenous testosterone. 61 active patents protecting 1 drugs from 1+ originators. First major cliff: 2027. Daily refresh.

1
Approved drugs
61
Active US patents
65/100
Avg vulnerability
—
Annual revenue covered

Originators in Deficiency Or Absence Of Endogenous Testosterone

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Marius 61 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating deficiency or absence of endogenous testosterone. Each bar = one year. Y-axis scaled to peak year (34 patents).

5
27
6
29
34
30
6
33
1
37
4
39
1
40
4
41

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Aveed
TESTOSTERONE UNDECANOATE
 Marius 61 65 — 2027-01-06

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
11331325 Aveed method of use 88 2027-01-06
11331325 Aveed method of use 88 2027-01-06
11331325 Aveed method of use 88 2027-01-06
8338395 Aveed method of use 85 2027-05-08
8865695 Aveed method of use 83 2029-01-08
11304960 Aveed method of use 83 2029-01-08
8778922 Aveed method of use 83 2029-01-08
11426416 Aveed method of use 76 2030-04-12
11426416 Aveed method of use 76 2030-04-12
11426416 Aveed method of use 76 2030-04-12

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
10617696 Aveed composition of matter 10 2030-04-12
10617696 Aveed composition of matter 10 2030-04-12
10617696 Aveed composition of matter 10 2030-04-12
8778916 Aveed formulation 48 2030-04-12
8778916 Aveed formulation 48 2030-04-12
8778916 Aveed formulation 48 2030-04-12
11590146 Aveed formulation 56 2030-12-31
10576090 Aveed formulation 56 2030-12-31
11590146 Aveed formulation 56 2030-12-31
10576090 Aveed formulation 56 2030-12-31

Related